CA2480683A1 - Unite de liaison de systemes therapeutiques transdermiques separables individuellement - Google Patents

Unite de liaison de systemes therapeutiques transdermiques separables individuellement Download PDF

Info

Publication number
CA2480683A1
CA2480683A1 CA002480683A CA2480683A CA2480683A1 CA 2480683 A1 CA2480683 A1 CA 2480683A1 CA 002480683 A CA002480683 A CA 002480683A CA 2480683 A CA2480683 A CA 2480683A CA 2480683 A1 CA2480683 A1 CA 2480683A1
Authority
CA
Canada
Prior art keywords
active substance
unit according
transdermal
active substances
individually separable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002480683A
Other languages
English (en)
Inventor
Klaus M. Wilsmann
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Gruenenthal GmbH
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2480683A1 publication Critical patent/CA2480683A1/fr
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne une unité de liaison réunissant des systèmes thérapeutiques transdermiques séparables individuellement.
CA002480683A 2002-03-27 2003-03-22 Unite de liaison de systemes therapeutiques transdermiques separables individuellement Abandoned CA2480683A1 (fr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10213772A DE10213772A1 (de) 2002-03-27 2002-03-27 Zusammenhängende Einheit aus vereinzelbaren transdermalen therapeutischen Systemen
DE10213772.2 2002-03-27
PCT/EP2003/003004 WO2003079962A2 (fr) 2002-03-27 2003-03-22 Unite de liaison de systemes therapeutiques transdermiques separables individuellement

Publications (1)

Publication Number Publication Date
CA2480683A1 true CA2480683A1 (fr) 2003-10-02

Family

ID=27816006

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002480683A Abandoned CA2480683A1 (fr) 2002-03-27 2003-03-22 Unite de liaison de systemes therapeutiques transdermiques separables individuellement

Country Status (9)

Country Link
EP (1) EP1490039A2 (fr)
JP (1) JP2005520844A (fr)
AR (1) AR039137A1 (fr)
AU (1) AU2003226695B2 (fr)
CA (1) CA2480683A1 (fr)
DE (1) DE10213772A1 (fr)
PE (1) PE20031015A1 (fr)
PL (1) PL370886A1 (fr)
WO (1) WO2003079962A2 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE0400685D0 (sv) * 2004-03-19 2004-03-19 Pfizer Health Ab Means for transdermal administration of nicotine
DE102004045599A1 (de) * 2004-09-17 2006-03-23 Grünenthal GmbH System zur sequentiellen, transdermalen Verabreichung von systemisch wirksamen Substanzen
JP4782438B2 (ja) * 2005-02-17 2011-09-28 日東電工株式会社 貼付製剤
DE202005014347U1 (de) * 2005-09-09 2007-01-18 Grünenthal GmbH Applikationssystem für ein wirkstoffhaltiges Pflaster und Wirkstoffabgaberegulierungsmittel
DE102006011340A1 (de) * 2006-03-09 2007-09-20 Grünenthal GmbH Wirkstoffhaltige Pflaster mit verbesserter Handhabung
DE102006054731B4 (de) 2006-11-21 2013-02-28 Lts Lohmann Therapie-Systeme Ag Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie
EP2394617B1 (fr) * 2010-06-10 2013-12-11 MedSkin Solutions Dr. Suwelack AG Biomatrices perforées en forme de couches
AU2011305600B2 (en) 2010-09-23 2016-05-19 Aquestive Therapeutics, Inc. Method and system for forming a pharmaceutical product directly onto a packaging surface
AP4036A (en) 2011-12-12 2017-02-22 Lohmann Therapie Syst Lts Transdermal delivery system comprising buprenorphine
EP3106153A1 (fr) 2013-06-04 2016-12-21 LTS LOHMANN Therapie-Systeme AG Système d'administration transdermique
EP3458306B1 (fr) 2016-05-18 2020-12-16 Shanghai Yanfeng Jinqiao Automotive Trim Systems Co., Ltd. Ensemble console pour intérieur de véhicule
US11572723B2 (en) 2019-02-27 2023-02-07 Shanghai Yanfeng Jinqiao Automotive Triim Systems Co. Ltd. Vehicle interior component
CN111359441B (zh) * 2020-03-25 2022-02-15 青岛科技大学 一种碱性pH响应聚合物纳米容器填充耐氯反渗透膜的制备方法

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2449865B2 (de) * 1974-10-17 1981-06-19 Schering Ag Berlin Und Bergkamen, 1000 Berlin Folienförmiges Arzneimittel
EP0252459A1 (fr) * 1986-07-07 1988-01-13 Schering Corporation Système d'apport compartimenté agissant à travers la peau
DE3630603A1 (de) * 1986-09-09 1988-03-10 Desitin Arzneimittel Gmbh Darreichungs- und dosierungsform fuer arzneimittelwirkstoffe, reagentien oder dergleichen sowie verfahren zu deren herstellung
DE3722775A1 (de) * 1987-07-09 1989-01-19 Lohmann Therapie Syst Lts Transdermales therapeutisches system
DE3911617A1 (de) * 1988-10-12 1990-04-19 Klaus Brueckner Darreichungsform fuer arzneistoffe
CA2090598A1 (fr) * 1992-03-04 1993-09-05 Kirti Himatlal Valia Patch titrable transdermique et methode d'administration de substances therapeutiques
DE4223004A1 (de) * 1992-07-13 1994-01-20 Liedtke Pharmed Gmbh Einzeldosierte halbfeste topische Arzneiform zur Transdermaltherapie
US5242433A (en) * 1992-12-07 1993-09-07 Creative Products Resource Associates, Ltd. Packaging system with in-tandem applicator pads for topical drug delivery
DE19503336C2 (de) * 1995-02-02 1998-07-30 Lohmann Therapie Syst Lts Arzneiform zur Abgabe von Wirkstoffen an Wunden, Verfahren zu ihrer Herstellung und ihre Verwendung
DE29511878U1 (de) * 1995-07-22 1996-11-28 Labtec Gmbh Transdermale Therapeutische Systeme
DE19900645C2 (de) * 1999-01-11 2003-03-20 Deotexis Inc Transdermales therapeutisches System
US6221384B1 (en) * 1999-11-05 2001-04-24 Anthony C. Pagedas Segmented transdermal dosage unit
US6682757B1 (en) * 2000-11-16 2004-01-27 Euro-Celtique, S.A. Titratable dosage transdermal delivery system

Also Published As

Publication number Publication date
DE10213772A1 (de) 2003-10-09
JP2005520844A (ja) 2005-07-14
EP1490039A2 (fr) 2004-12-29
AU2003226695B2 (en) 2008-10-02
AR039137A1 (es) 2005-02-09
WO2003079962A3 (fr) 2003-12-24
PL370886A1 (en) 2005-05-30
AU2003226695A1 (en) 2003-10-08
PE20031015A1 (es) 2004-01-17
WO2003079962A2 (fr) 2003-10-02

Similar Documents

Publication Publication Date Title
AU707933B2 (en) Transdermal delivery system
EP0117027B1 (fr) Dispositif d'administration d'un médicament
US5091186A (en) Biphasic transdermal drug delivery device
FI91599B (fi) Laastari vaikuttavien aineiden valvotusti jakamiseksi iholle
AU2003226695B2 (en) Assembled unit consisting of individually separable transdermal therapeutic systems
AU2004266563B2 (en) Transdermal patch incorporating active agent migration barrier layer
EP0174108B1 (fr) Dispositifs pour l'administration transdermique
SK113790A3 (en) Plaster as a therapeutic system, process for its manufacture and use thereof
US5863941A (en) Method and composition of a topical treatment of inner ear and labyrinth symptoms
KR960005148B1 (ko) 활성 물질의 국소적 또는 전신적 투여를 위한 약물의 단계 방출형 경피 투여 시스템
CZ20012230A3 (cs) Průhledná zařízení pro transdermální podání nikotinu
US20050118245A1 (en) Assembled unit consisting of individually separable, transdermal, therapeutic systems
Vachhal et al. Transdermal patches: updated review as a novel drug delivery system
AU2009353789A1 (en) Transdermal therapeutic system
AU2001270537A1 (en) Dosage of transdermal delivery systems
US20070212402A1 (en) Patch
EP1283706A1 (fr) Dosage pour systemes d'administration transdermique
KR19980701419A (ko) (s)-3-메틸-5-(1-메틸-2-피롤리데닐)-이속사졸 또는 약제학적으로 허용가능한 이의 염들 중 하나를 투여하기 위한 트랜스더멀 치료 시스템

Legal Events

Date Code Title Description
EEER Examination request
FZDE Dead